(Q46712818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

Fernanda Bruschi Priviero

7 January 2020

author

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mário A Claudino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Gilberto de Nucci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Edson Antunes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Juliana S Baracat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Cleber E Teixeira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Pharmacology and Physiology

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

728-734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

The new British Hypertension Society guidelines: a view from primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

NO-independent regulatory site on soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

NO-independent stimulators of soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Relaxing effects induced by the soluble guanylyl cyclase stimulator BAY 41-2272 in human and rabbit corpus cavernosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Inhibitory effects on human eosinophil chemotaxis in vitro by BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Sodium nitroprusside-induced cGMP-independent vasodilator responses in the perfused rabbit ovarian vascular bed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Mechanism of cGMP contribution to the vasodilator response to NO in rat middle cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

New insights into the intracellular mechanisms by which PGI2 analogues elicit vascular relaxation: cyclic AMP-independent, Gs-protein mediated-activation of MaxiK channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Inhibition by iloprost of the contractile effect of noradrenaline in mesenteric artery rings: Evidence for a possible calcium-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Inhibition of extracellular Ca(2+) entry by YC-1, an activator of soluble guanylyl cyclase, through a cyclic GMP-independent pathway in rat neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04262.X

10.1111/J.1440-1681.2005.04262.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16173929%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference